The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
Genetics of Type 1 Diabetes
Open accessAbstract
BACKGROUND: Type 1 diabetes, a multifactorial disease with a strong genetic component, is caused by the autoimmune destruction of pancreatic β cells. The major susceptibility locus maps to the HLA class II genes at 6p21, although more than 40 non-HLA susceptibility gene markers have been confirmed. CONTENT: Although HLA class II alleles account for up to 30%–50% of genetic type 1 diabetes risk, multiple non-MHC loci contribute to disease risk with smaller effects. These include the insulin, PTPN22, CTLA4, IL2RA, IFIH1, and other recently discovered loci. Genomewide association studies performed with high-density single-nucleotide–polymorphism genotyping platforms have provided evidence for a number of novel loci, although fine mapping and characterization of these new regions remain to be performed. Children born with the high-risk genotype HLADR3/4-DQ8 comprise almost 50% of children who develop antiislet autoimmunity by the age of 5 years. Genetic risk for type 1 diabetes can be further stratified by selection of children with susceptible genotypes at other diabetes genes, by selection of children with a multiple family history of diabetes, and/or by selection of relatives that are HLA identical to the proband. SUMMARY: Children with the HLA-risk genotypes DR3/4-DQ8 or DR4/DR4 who have a family history of type 1 diabetes have more than a 1 in 5 risk for developing islet autoantibodies during childhood, and children with the same HLA-risk genotype but no family history have approximately a 1 in 20 risk. Determining extreme genetic risk is a prerequisite for the implementation of primary prevention trials, which are now underway for relatives of individuals with type 1 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
The Wellcome Trust Case Control Consortium, Management Committee, Burton, P. R., Clayton, D. G., Cardon, L. R., Craddock, N., Deloukas, P., Duncanson, A., Kwiatkowski, D. P., McCarthy, M. I., et al. (2007) · Nature · doi:10.1038/nature05911 · Cited by 9,442
Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease
Ueda, H., Howson, J. M. M., Esposito, L., Heward, J., Snook, Chamberlain, G., Rainbow, D. B., Hunter, K. M. D., Smith, A. N., Di Genova, G., et al. (2003) · Nature · doi:10.1038/nature01621 · Cited by 2,175
The Type 1 Diabetes Genetics Consortium, Barrett, J. C., Clayton, D. G., Concannon, P., Akolkar, B., Cooper, J. D., Erlich, H. A., Julier, C., Morahan, G., Nerup, J., et al. (2009) · Nature Genetics · doi:10.1038/ng.381 · Cited by 1,746
Begovich, A. B., Carlton, V. E. H., Honigberg, L. A., Schrodi, S. J., Chokkalingam, A. P., Alexander, H. C., Ardlie, K. G., Huang, Q., Smith, A. M., Spoerke, J. M., et al. (2004) · The American Journal of Human Genetics · doi:10.1086/422827 · Cited by 1,502
Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes
Finland, G. O. T. 1. D. I., Todd, J. A., the Wellcome Trust Case Control Consortium, Walker, N. M., Cooper, J. D., Smyth, D. J., Downes, K., Plagnol, V., Bailey, R., Nejentsev, S., et al. (2007) · Nature Genetics · doi:10.1038/ng2068 · Cited by 1,456
A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes
Bottini, N., Musumeci, L., Alonso, A., Rahmouni, S., Nika, K., Rostamkhani, M., MacMurray, J., Meloni, G. F., Lucarelli, P., Pellecchia, M., et al. (2004) · Nature Genetics · doi:10.1038/ng1323 · Cited by 1,424
Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants
Wellcome Trust Case Control Consortium, & The Australo-Anglo-American Spondylitis Consortium (TASC) (2007) · Nature Genetics · doi:10.1038/ng.2007.17 · Cited by 1,374
A genome-wide search for human type 1 diabetes susceptibility genes
Davies, J. L., Kawaguchi, Y., Bennett, S. T., Copeman, J. B., Cordell, H. J., Pritchard, L. E., Reed, P. W., Gough, S. C. L., Jenkins, S. C., Palmer, S. M., et al. (1994) · Nature · doi:10.1038/371130a0 · Cited by 1,276 · cited 1×
“The most important and consistent evidence of linkage for T1D has been in the HLA region on chromosome 6p21 (10, 16).”
BackgroundPugliese, A., Zeller, M., Fernandez, A., Zalcberg, L. J., Bartlett, R. J., Ricordi, C., Pietropaolo, M., Eisenbarth, G. S., Bennett, S. T., & Patel, D. D. (1997) · Nature Genetics · doi:10.1038/ng0397-293 · Cited by 945
Onkamo, P., Väänänen, S., Karvonen, M., & Tuomilehto, J. (1999) · Diabetologia · doi:10.1007/s001250051309 · Cited by 892
Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus
Vafiadis, P., Bennett, S. T., Todd, J. A., Nadeau, J., Grabs, R., Goodyer, C. G., Wickramasinghe, S., Colle, E., & Polychronakos, C. (1997) · Nature Genetics · doi:10.1038/ng0397-289 · Cited by 809 · cited 1×
“The allelic variant associated with protection from T1D has been associated with greater expression of insulin messenger RNA within the thymus (33, 34).”
BackgroundNistico, L. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.7.1075 · Cited by 809
HLA DR-DQ Haplotypes and Genotypes and Type 1 Diabetes Risk
Erlich, H., Valdes, A. M., Noble, J., Carlson, J. A., Varney, M., Concannon, P., Mychaleckyj, J. C., Todd, J. A., Bonella, P., Fear, A. L., et al. (2008) · Diabetes · doi:10.2337/db07-1331 · Cited by 790 · cited 1×
“Technological progress has facilitated the study of the genome to map disease-susceptibility genes for multifactorial diseases, including the increasing availability of microsatellite markers, single-nucleotide polymorphisms (SNPs), automated typing technology (6), and recently, whole-genome SNP analysis (7).”
BackgroundBell, G. I., Horita, S., & Karam, J. H. (1984) · Diabetes · doi:10.2337/diab.33.2.176 · Cited by 743
Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variant
Vang, T., Congia, M., Macis, M. D., Musumeci, L., Orrú, V., Zavattari, P., Nika, K., Tautz, L., Taskén, K., Cucca, F., et al. (2005) · Nature Genetics · doi:10.1038/ng1673 · Cited by 728
Smyth, D. J., Cooper, J. D., Bailey, R., Field, S., Burren, O., Smink, L. J., Guja, C., Ionescu-Tirgoviste, C., Widmer, B., Dunger, D. B., et al. (2006) · Nature Genetics · doi:10.1038/ng1800 · Cited by 688
Genetic Association of the R620W Polymorphism of Protein Tyrosine Phosphatase PTPN22 with Human SLE
Kyogoku, C., Ortmann, W. A., Lee, A., Selby, S., Carlton, V. E. H., Chang, M., Ramos, P., Baechler, E. C., Batliwalla, F. M., Novitzke, J., et al. (2004) · The American Journal of Human Genetics · doi:10.1086/423790 · Cited by 672
Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A
The Wellcome Trust Case Control Consortium, Nejentsev, S., Howson, J. M. M., Walker, N. M., Szeszko, J., Field, S. F., Stevens, H. E., Reynolds, P., Hardy, M., King, E., et al. (2007) · Nature · doi:10.1038/nature06406 · Cited by 570
A genome-wide association study identifies KIAA0350 as a type 1 diabetes gene
Hakonarson, H., Grant, S. F. A., Bradfield, J. P., Marchand, L., Kim, C. E., Glessner, J. T., Grabs, R., Casalunovo, T., Taback, S. P., Frackelton, E. C., et al. (2007) · Nature · doi:10.1038/nature06010 · Cited by 542
Meta-analysis of genome-wide association study data identifies additional type 1 diabetes risk loci
Cooper, J. D., Smyth, D. J., Smiles, A. M., Plagnol, V., Walker, N. M., Allen, J. E., Downes, K., Barrett, J. C., Healy, B. C., Mychaleckyj, J. C., et al. (2008) · Nature Genetics · doi:10.1038/ng.249 · Cited by 531
Kouki, T., Sawai, Y., Gardine, C. A., Fisfalen, M.-E., Alegre, M.-L., & DeGroot, L. J. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.11.6606 · Cited by 505
Smyth, D., Cooper, J. D., Collins, J. E., Heward, J. M., Franklyn, J. A., Howson, J. M. M., Vella, A., Nutland, S., Rance, H. E., Maier, L., et al. (2004) · Diabetes · doi:10.2337/diabetes.53.11.3020 · Cited by 503
Noble, J. A., Valdes, A. M., Cook, M., Klitz, W., Thomson, G., & Erlich, H. A. (1996) · PubMed · Cited by 476
A functional variant of SUMO4, a new IκBα modifier, is associated with type 1 diabetes
Guo, D., Li, M., Zhang, Y., Yang, P., Eckenrode, S., Hopkins, D., Zheng, W., Purohit, S., Podolsky, R. H., Muir, A., et al. (2004) · Nature Genetics · doi:10.1038/ng1391 · Cited by 431
Lowe, C. E., Cooper, J. D., Brusko, T., Walker, N. M., Smyth, D. J., Bailey, R., Bourget, K., Plagnol, V., Field, S., Atkinson, M., et al. (2007) · Nature Genetics · doi:10.1038/ng2102 · Cited by 424
Rewers, M., Bugawan, T. L., Norris, J. M., Blair, A., Beaty, B., Hoffman, M., McDuffie, R. S., Hamman, R. F., Klingensmith, G., Eisenbarth, G. S., et al. (1996) · Diabetologia · doi:10.1007/s001250050514 · Cited by 422 · cited 1×
“4% of newborns and almost 50% of children developing antiislet autoimmunity by age 5 (DAISY study) (18, 70).”
BackgroundSelf-citationMarron, M. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.8.1275 · Cited by 407
Genetic Liability of Type 1 Diabetes and the Onset Age Among 22,650 Young Finnish Twin Pairs
Hyttinen, V., Kaprio, J., Kinnunen, L., Koskenvuo, M., & Tuomilehto, J. (2003) · Diabetes · doi:10.2337/diabetes.52.4.1052 · Cited by 394
Concordance for islet autoimmunity among monozygotic twins
Redondo, M. J., Jeffrey, J., Fain, P. R., Eisenbarth, G. S., & Orban, T. (2008) · New England Journal of Medicine · doi:10.1056/nejmc0805398 · Cited by 353
Vella, A., Cooper, J. D., Lowe, C. E., Walker, N., Nutland, S., Widmer, B., Jones, R., Ring, S. M., McArdle, W., Pembrey, M. E., et al. (2005) · The American Journal of Human Genetics · doi:10.1086/429843 · Cited by 352
Barker, J. M., Barriga, K. J., Yu, L., Miao, D., Erlich, H. A., Norris, J. M., Eisenbarth, G. S., & Rewers, M. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031887 · Cited by 348
Self-citationConcannon, P., Gogolin-Ewens, K. J., Hinds, D. A., Wapelhorst, B., Morrison, V. A., Stirling, B., Mitra, M., Farmer, J., Williams, S. R., Cox, N. J., et al. (1998) · Nature Genetics · doi:10.1038/985 · Cited by 338
Redondo, M. J., Yu, L., Hawa, M., Mackenzie, T., Pyke, D. A., Eisenbarth, G. S., & Leslie, R. D. G. (2001) · Diabetologia · doi:10.1007/s001250051626 · Cited by 322 · cited 2×
“Essentially all such twins who express “biochemical” antiislet autoantibodies progress to diabetes, even though this may not occur until after decades of follow-up (14, 15).”
BackgroundConcannon (2005) · doi:10.2337/diabetes.54.10.2995 · Cited by 257
Extreme genetic risk for type 1A diabetes
Aly, T. A., Ide, A., Jahromi, M. M., Barker, J. M., Fernando, M. S., Babu, S. R., Yu, L., Miao, D., Erlich, H. A., Fain, P. R., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606349103 · Cited by 257
Self-citationFourlanos, S., Varney, M. D., Tait, B. D., Morahan, G., Honeyman, M. C., Colman, P. G., & Harrison, L. C. (2008) · Diabetes Care · doi:10.2337/dc08-0239 · Cited by 228
Remapping the Insulin Gene/IDDM2 Locus in Type 1 Diabetes
Barratt, B. J., Payne, F., Lowe, C. E., Hermann, R., Healy, B. C., Harold, D., Concannon, P., Gharani, N., McCarthy, M. I., Olavesen, M. G., et al. (2004) · Diabetes · doi:10.2337/diabetes.53.7.1884 · Cited by 223
Barker, J. M., Goehrig, S. H., Barriga, K., Hoffman, M., Slover, R., Eisenbarth, G. S., Norris, J. M., Klingensmith, G. J., & Rewers, M. (2004) · Diabetes Care · doi:10.2337/diacare.27.6.1399 · Cited by 220
Self-citationGene Expression in Peripheral Blood Mononuclear Cells from Children with Diabetes
Kaizer, E. C., Glaser, C. L., Chaussabel, D., Banchereau, J., Pascual, V., & White, P. C. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0979 · Cited by 219
Association of the Vitamin D Metabolism Gene CYP27B1 With Type 1 Diabetes
Bailey, R., Cooper, J. D., Zeitels, L., Smyth, D. J., Yang, J. H. M., Walker, N. M., Hyppönen, E., Dunger, D. B., Ramos-Lopez, E., Badenhoop, K., et al. (2007) · Diabetes · doi:10.2337/db07-0652 · Cited by 210
Pugliese, A., Gianani, R., Moromisato, R., Awdeh, Z. L., Alper, C. A., Erlich, H. A., Jackson, R. A., & Eisenbarth, G. S. (1995) · Diabetes · doi:10.2337/diab.44.6.608 · Cited by 207
Moriyama, H., Abiru, N., Paronen, J., Sikora, K., Liu, E., Miao, D., Devendra, D., Beilke, J., Gianani, R., Gill, R. G., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1834450100 · Cited by 197
Redondo, M. J., Rewers, M., Yu, L., Garg, S., Pilcher, C. C., Elliott, R. B., & Eisenbarth, G. S. (1999) · BMJ · doi:10.1136/bmj.318.7185.698 · Cited by 181
Self-citationHummel, M., Bonifacio, E. E., Schmid, S., Walter, M., Knopff, A., & Ziegler, A. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-11-200406010-00009 · Cited by 173
Kavvoura, F. K., & Ioannidis, J. P. A. (2005) · American Journal of Epidemiology · doi:10.1093/aje/kwi165 · Cited by 173
Ramos‐Lopez, E., Brück, P., Jansen, T., Herwig, J., & Badenhoop, K. (2007) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.719 · Cited by 164
Follow-Up Analysis of Genome-Wide Association Data Identifies Novel Loci for Type 1 Diabetes
Grant, S. F. A., Qu, H.-Q., Bradfield, J. P., Marchand, L., Kim, C. E., Glessner, J. T., Grabs, R., Taback, S. P., Frackelton, E. C., Eckert, A. W., et al. (2009) · Diabetes · doi:10.2337/db08-1022 · Cited by 161
Hakonarson, H. H., Qu, H., Bradfield, J. P., Marchand, L., Kim, C., Glessner, J., Grabs, R., Casalunovo, T., Taback, S. P., Frackelton, E. C., et al. (2008) · Diabetes · doi:10.2337/db07-1305 · Cited by 153
Genetic Association Between a Lymphoid Tyrosine Phosphatase (PTPN22) and Type 1 Diabetes
Zheng, W., & She, J. (2005) · Diabetes · doi:10.2337/diabetes.54.3.906 · Cited by 145
The HLA class I A locus affects susceptibility to type 1 diabetes
Noble, J. A., Valdes, A. M., Bugawan, T. L., Apple, R. J., Thomson, G. J., & Erlich, H. A. (2002) · Human Immunology · doi:10.1016/s0198-8859(02)00421-4 · Cited by 128
Valdes, A. M., Erlich, H. A., & Noble, J. A. (2005) · Human Immunology · doi:10.1016/j.humimm.2004.12.001 · Cited by 124
Blomhoff, A., Lie, B. A., Myhre, A. G., Kemp, E. H., Weetman, A. P., Akselsen, H. E., Huseby, E. S., & Undlien, D. E. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031854 · Cited by 115
Wang, X., Jia, S., Geoffrey, R., Alemzadeh, R., Ghosh, S., & Hessner, M. J. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.3.1929 · Cited by 112
Walter, M., Albert, E. D., Conrad, M., Keller, E., Hummel, M., Ferber, K. M., Barratt, B. J., Todd, J. A., Ziegler, A., & Bonifacio, E. E. (2003) · Diabetologia · doi:10.1007/s00125-003-1082-z · Cited by 110
Zipris, D., Lien, E., Nair, A., Xie, J. X., Greiner, D. L., Mordes, J. P., & Rossini, A. A. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.2.693 · Cited by 101
Bonifacio, E. E., Hummel, M., Walter, M., Schmid, S., & Ziegler, A. (2004) · Diabetes Care · doi:10.2337/diacare.27.11.2695 · Cited by 97
Trends in high-risk HLA susceptibility genes among Colorado youth with type 1 diabetes
Vehik, K., Hamman, R. F., Lezotte, D., Norris, J. M., Klingensmith, G. J., Rewers, M., & Dabelea, D. (2008) · Diabetes Care · doi:10.2337/dc07-2210 · Cited by 82
Self-citationAchenbach, P., Barker, J. M., & Bonifacio, E. E. (2008) · Current Diabetes Reports · doi:10.1007/s11892-008-0017-y · Cited by 75
Cooperative Roles of CTLA-4 and Regulatory T Cells in Tolerance to an Islet Cell Antigen
Eggena, M. P., Walker, L. S. K., Nagabhushanam, V., Barron, L., Chodos, A. H., & Abbas, A. K. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040124 · Cited by 73
Howson, J. M. M., Dunger, D. B., Nutland, S. L., Stevens, H. E., Wicker, L. S., & Todd, J. A. (2007) · Diabetologia · doi:10.1007/s00125-007-0603-6 · Cited by 70
Association of the PTPN22/LYP gene with type 1 diabetes
Steck, A. K., Liu, S. M., McFann, K., Barriga, K. J., Babu, S. R., Eisenbarth, G. S., Rewers, M., & She, J. (2006) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2006.00202.x · Cited by 61
Self-citationHathout, E. H., Hartwick, N., Fagoaga, O. R., Colacino, A. R., Sharkey, J., Racine, M. S., Nelsen-Cannarella, S., & Mace, J. (2003) · PEDIATRICS · doi:10.1542/peds.111.4.860 · Cited by 53
Steck, A. K., Zhang, W., Bugawan, T. L., Barriga, K. J., Blair, A., Erlich, H. A., Eisenbarth, G. S., Norris, J. M., & Rewers, M. (2009) · Diabetes · doi:10.2337/db08-1179 · Cited by 52
Self-citationBaschal, E. E., Aly, T. A., Babu, S. R., Fernando, M. S., Yu, L., Miao, D., Barriga, K. J., Norris, J. M., Noble, J. A., Erlich, H. A., et al. (2007) · Diabetes · doi:10.2337/db07-0029 · Cited by 52
Self-citationDPB1 Alleles Are Associated With Type 1 Diabetes Susceptibility in Multiple Ethnic Groups
Cruz, T. D., Valdes, A. M., Santiago, A., de Llado, T. F., Raffel, L. J., Zeidler, A., Rotter, J. I., Erlich, H. A., Rewers, M., Bugawan, T. L., et al. (2004) · Diabetes · doi:10.2337/diabetes.53.8.2158 · Cited by 50
Self-citationExtreme genetic risk for type 1A diabetes in the post-genome era
Baschal, E. E., & Eisenbarth, G. S. (2008) · Journal of Autoimmunity · doi:10.1016/j.jaut.2008.03.003 · Cited by 48
Type 1 diabetes and the OAS gene cluster: association with splicing polymorphism or haplotype?
Tessier, M.-C., Qu, H.-Q., Fréchette, R., Bacot, F., Grabs, R., Taback, S. P., Lawson, M. L., Kirsch, S. E., Hudson, T., & Polychronakos, C. (2005) · Journal of Medical Genetics · doi:10.1136/jmg.2005.035212 · Cited by 46
Planas, R., Pujol‐Borrell, R., & Vives‐Pi, M. (2010) · Immunology Letters · doi:10.1016/j.imlet.2010.08.001 · Cited by 41
Secondary Attack Rate of Type 1 Diabetes in Colorado Families
Steck, A. K., Barriga, K. J., Emery, L. M., Fiallo-Scharer, R. V., Gottlieb, P. A., & Rewers, M. (2005) · Diabetes Care · doi:10.2337/diacare.28.2.296 · Cited by 40
Self-citationThe association between the IFIH1 locus and type 1 diabetes
Qu, H., Marchand, L., Grabs, R., & Polychronakos, C. (2007) · Diabetologia · doi:10.1007/s00125-007-0895-6 · Cited by 38
A linkage analysis of the CTLA4 gene region in Finnish patients with type 1 diabetes
Turpeinen, H., Laine, A., Hermann, R., Simell, O., Veijola, R., Knip, M., & Ilonen, J. (2003) · European Journal of Immunogenetics · doi:10.1046/j.1365-2370.2003.00407.x · Cited by 32
Deschamps, I., Boitard, C., Hors, J., Busson, M., Marcelli-Barge, A., Mogenet, A., & Robert, J.-J. (1992) · Diabetologia · doi:10.1007/bf00401424 · Cited by 30
Noble, J. A., Martin, A., Valdes, A. M., Lane, J. A., Galgani, A., Petrone, A., Lorini, R., Pozzilli, P., Buzzetti, R., & Erlich, H. A. (2008) · Human Immunology · doi:10.1016/j.humimm.2008.02.003 · Cited by 26
The role of DQ alpha–beta heterodimers in genetic susceptibility to insulin‐dependent diabetes
Deschamps, I., & Khalil, I. (1993) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610090202 · Cited by 24
Ide, A., Babu, S. R., Robles, D. T., Wang, T., Erlich, H. A., Bugawan, T. L., Rewers, M., Fain, P. R., & Eisenbarth, G. S. (2005) · Journal of Clinical Immunology · doi:10.1007/s10875-005-4826-3 · Cited by 9
Self-citation
Cited by
Present yourself! by MHC class I and MHC class II molecules
Rock, K. L., Reits, E., & Neefjes, J. (2016) · Trends in Immunology · doi:10.1016/j.it.2016.08.010 · Cited by 814
Genetics of Type 2 Diabetes—Pitfalls and Possibilities
Prasad, R., & Groop, L. (2015) · Genes · doi:10.3390/genes6010087 · Cited by 458
Noble, J. A., & Erlich, H. A. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a007732 · Cited by 335
The Pathogenesis and Natural History of Type 1 Diabetes
Atkinson, M. A. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a007641 · Cited by 314
Immune checkpoint inhibitors and type 1 diabetes mellitus: a case report and systematic review
de Filette, J. M. K., Pen, J. J., Decoster, L., Vissers, T., Bravenboer, B., Van der Auwera, B. J., Gorus, F. K., Roep, B. O., Aspeslagh, S., Neyns, B., et al. (2019) · European Journal of Endocrinology · doi:10.1530/eje-19-0291 · Cited by 275
Metadata
- Authors
- Steck, A. K., & Rewers, M. J.
- Venue
- Clinical Chemistry
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-02-01
- Volume
- 57
- Issue
- 2
- Pages
- 176-185
- ISSN
- 0009-9147 (ISSN-L)
- 1530-8561
- OpenAlex
- W2043107413
- Cited by
- 310
- References
- 75
- FWCI
- 11.15
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.